Orion - Changes board/management/auditors

Change in Orion Group Executive Management Board as of 1 Jan 2011

ORION CORPORATION    STOCK EXCHANGE RELEASE  24 Sept  2010  AT 01.05 PM EET

Mrs. Riitta Vartiainen, Senior Vice President responsible for the Business
Development and Support line function of the Orion Group and member of the
Executive Management Board of the Orion Group, will step down from the Executive
Management Board as of 1 January 2011 and retire in February 2011.

In this connection, Orion will implement an organizational change in which the
departments of the Business Development and Support line function are
transferred to other organizations of the Group as of 1 January 2011.

Timo Lappalainen, President and CEO, says:"Riitta Vartiainen has served the Orion Group since 1988, having successfully
headed a variety of operations in the company, most recently the Business
Development and Support function. New operations for Orion have been created
under her leadership, among them latest the India Liaison Office serving all
Orion organizations. I'm pleased to wish all the best for Riitta in her upcoming
new phase of life."


Orion Corporation


Timo Lappalainen                      Olli Huotari
President and CEO                    SVP, Corporate Functions


Contact person:
Timo Lappalainen, President and CEO, phone +358 50 966 3692



Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
Homepage:www.orion.fi


Orion is an innovative European R&D-based pharmaceutical and diagnostic company
with a special emphasis on developing medicinal treatments and diagnostic tests
for global markets. Orion develops, manufactures and markets human and
veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic
tests. Orion's pharmaceutical R&D focuses on the following core therapy areas:
central nervous system drugs, cancer and critical care drugs, and Easyhaler(®)
pulmonary drugs.

The Group's net sales in 2009 amounted to EUR 772 million. The Company invested
EUR 95 million in research and development. At the end of 2009, the Group had a
total of 3,100 employees, of whom 2,500 worked in Finland and 600 in other
European countries. Orion's A and B shares are listed on NASDAQ OMX Helsinki.


[HUG#1446689]